Farallon Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Farallon Capital Management's RGEN Position: Q2 2022 in Review
Farallon Capital Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 222,979 shares — an estimated $41.9M sold.
Farallon Capital Management first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $41.9M in Q1 2022. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.
- Farallon Capital Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
- Farallon Capital Management sold 222,979 Repligen shares in Q2 2022, an estimated $41.9M.
- Farallon Capital Management first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
- Farallon Capital Management's Repligen position peaked at $41.9M in Q1 2022.
- 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.
Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.